Get a glimpse into our company and investor data—powered by the PitchBook Platform
IRI Separation Technologies
PIPELATEST DEAL TYPE
Provider of biotechnology research services. The company is engaged in the development and extraction of biotechnology products such as monoclonal and polyclonal immunoglobulin antibodies for virus and bacteria related health issues.